US Stock Insider Trading | Forian disclosed one insider transaction on February 18

K-LinePoet · 2026-02-20T18:23:35+00:00

Forian (FORA) executive VESEY MICHAEL sold 4,918 shares on February 13, 2026, at a price of $2.10 per share, with a total transaction amount of approximately $10,300. The company focuses on providing data analytics solutions for the life sciences and healthcare industries, and was founded in 2020.

K-LinePoet

2026-02-20 18:23:35

Abstract generation in progress

On February 18, 2026, Forian (FORA) disclosed one insider trading transaction. Executive VESEY MICHAEL sold 4,918 shares on February 13, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 18, 2026	Executive	VESEY MICHAEL	February 13, 2026	Sell	4,918	2.10	10,300
January 14, 2026	Executive	VESEY MICHAEL	January 12, 2026	Sell	18,100	2.12	38,300
November 12, 2025	Executive	VESEY MICHAEL	November 10, 2025	Sell	17,800	2.15	38,200
November 4, 2025	Executive	McGrail Caroline Strickland	November 2, 2025	Buy	150,000	2.24	336,000
September 4, 2025	Executive	VESEY MICHAEL	September 2, 2025	Sell	3,300	2.11	6,963
July 17, 2025	Director	Dublin Adam H	July 15, 2025	Buy	200,000	1.93	386,000
July 17, 2025	Shareholder with over 10%	Wygod Max C	July 15, 2025	Buy	200,000	1.93	386,000
July 17, 2025	Executive	VESEY MICHAEL	July 15, 2025	Buy	200,000	1.93	386,000
March 7, 2025	Executive	Spaniel Edward Francis Jr	March 5, 2025	Sell	7,769	2.06	16,000
February 18, 2025	Executive	Spaniel Edward Francis Jr	February 13, 2025	Sell	5,426	2.76	15,000

[Company Information]

Forian Inc. is a Delaware corporation incorporated by MOR on October 15, 2020, for mergers and contributions. The company was re-registered in Maryland on January 9, 2026. Forian is a leading provider of data science-driven information and analytics solutions for the life sciences, healthcare, and financial services industries. The company offers a unique data management capability and proprietary rich information and analytics solutions to help clients optimize and measure operational, clinical, and financial performance. Their subscription and service-based solutions cover life sciences, pharmaceutical services, healthcare payers, providers, and financial services industries.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.